Next Article in Journal
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer
Previous Article in Journal
Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade
Previous Article in Special Issue
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6152; https://doi.org/10.3390/cancers14246152
Action Date Notes Link
article pdf uploaded. 13 December 2022 16:19 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6152/pdf-vor
article supplementary file uploaded. 13 December 2022 16:19 CET - https://www.mdpi.com/2072-6694/14/24/6152#supplementary
article xml file uploaded 21 December 2022 17:31 CET Original file -
article xml uploaded. 21 December 2022 17:31 CET Update https://www.mdpi.com/2072-6694/14/24/6152/xml
article pdf uploaded. 21 December 2022 17:31 CET Updated version of record https://www.mdpi.com/2072-6694/14/24/6152/pdf
article html file updated 21 December 2022 17:32 CET Original file -
article html file updated 1 March 2023 04:03 CET Update -
article html file updated 4 March 2023 21:26 CET Update https://www.mdpi.com/2072-6694/14/24/6152/html
Back to TopTop